Mural Oncology plc (NASDAQ: MURA) on Friday, plunged -5.36% from the previous trading day, before settling in for the closing price of $1.68. Within the past 52 weeks, MURA’s price has moved between $0.95 and $4.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 25.33%. With a float of $12.64 million, this company’s outstanding shares have now reached $17.27 million.
Let’s look at the performance matrix of the company that is accounted for 116 employees. In terms of profitability, gross margin is 50.0%, operating margin of -3885.8%, and the pretax margin is -4213.97%.
Mural Oncology plc (MURA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mural Oncology plc is 25.61%, while institutional ownership is 54.86%. The most recent insider transaction that took place on Jul 22 ’25, was worth 6,379. In this transaction an insider of this company sold 2,572 shares at a rate of $2.48, taking the stock ownership to the 68,834 shares. Before that another transaction happened on Jul 18 ’25, when Company’s insider sold 2,158 for $2.48, making the entire transaction worth $5,352. This insider now owns 71,406 shares in total.
Mural Oncology plc (MURA) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -1.87 earnings per share (EPS) for the period topping the consensus outlook (set at -1.96) by 0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.33% per share during the next fiscal year.
Mural Oncology plc (NASDAQ: MURA) Trading Performance Indicators
Mural Oncology plc (MURA) is currently performing well based on its current performance indicators. A quick ratio of 2.87 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.58, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -0.39 in one year’s time.
Technical Analysis of Mural Oncology plc (MURA)
Mural Oncology plc (NASDAQ: MURA) saw its 5-day average volume 0.54 million, a negative change from its year-to-date volume of 2.07 million. As of the previous 9 days, the stock’s Stochastic %D was 16.67%.
During the past 100 days, Mural Oncology plc’s (MURA) raw stochastic average was set at 18.82%, which indicates a significant increase from 6.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1460 in the past 14 days, which was lower than the 0.1475 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4162, while its 200-day Moving Average is $3.0393.
